Executive Summary: As the global demand for vision correction surges, transparent contact lenses have evolved from simple corrective tools into high-tech medical devices. This white paper explores the manufacturing excellence of China's leading exporters, focusing on material science, CNC automation, and the transition toward Silicone Hydrogel technologies.
The global contact lens market is projected to reach $15 billion by 2026. Transparent lenses (Clear Lenses) account for over 75% of this volume, driven by an aging global population and the rising prevalence of myopia in younger demographics. Chinese factories are now at the forefront, bridging the gap between high-volume production and medical-grade precision.
The industry is shifting from traditional HEMA-based Hydrogels to high-oxygen permeability (Dk/t) Silicone Hydrogels. Our research at Guangzhou Dewy Lenses focuses on "Bio-Mimetic" surfaces that reduce protein adsorption, ensuring all-day comfort for digital device users.
China's export infrastructure offers unparalleled lead-time advantages. By integrating fully automatic CNC production lines with semi-molding processes, we achieve a 99.9% consistency rate, meeting the stringent requirements of EU (CE) and US (FDA) standards.
Established in 1996, Guangzhou Dewy Lenses Co., Ltd. is a leading high-tech enterprise integrating product design, research, and large-scale production of premium soft contact lenses and care products.
As a high-tech national enterprise, we integrate product design, research, and large-scale production of soft hydrophilic contact lenses and care products. Our commitment to excellence ensures every lens meets the highest standards of comfort, clarity, and safety.
Professional buyers and optometry chains require more than just a product; they require a robust partnership. We provide comprehensive macro-industry solutions to streamline your procurement.
For brands looking to launch their own line of transparent lenses, we offer full private-label support including packaging design (as seen in our Eyeshare series) and material specification matching.
By eliminating intermediaries, we provide transparent pricing and real-time tracking from our Guangzhou facility to your warehouse, ensuring cold-chain integrity where necessary.
Navigating medical device registration is complex. We provide technical dossiers, clinical trial data, and local compliance certificates to expedite your market entry in the Americas, Europe, and SE Asia.
Transitioning to 3rd Gen Silicone Hydrogels with 150+ Dk/t.
Integration of Smart-Hydra surface technology for dry-eye relief.
Aspheric lens design for HD night vision and reduced glare.
Eco-friendly biodegradable blister packaging development.
Researching embedded micro-sensors for intraocular pressure monitoring.
Competitive advantage stems from the combination of high-precision CNC automation and a vertically integrated supply chain. This allows factories like Dewy Lenses to offer medical-grade quality at a cost-to-performance ratio that is superior to traditional Western manufacturers.
We utilize high-temperature sterilization cabinets and a class 100,000 cleanroom environment. Every lens undergoes OQC (Outgoing Quality Control) and is verified for base curve, diameter, and power accuracy before sealing.
Yes, while we are a large-scale manufacturer, we offer tiered procurement programs. For stock items like our Eyeshare packaging and standard clear lenses, we support smaller initial orders to help brands scale.
Traditional Hydrogel lenses rely on water content to transport oxygen. Silicone Hydrogel lenses allow oxygen to pass directly through the material, making them much safer for long-duration wear and reducing the risk of corneal hypoxia.
Dewylenses
